Interview: Alejandro Arias – CEO, iLS Clinical Research, Mexico
Positioning itself as a flexible local CRO with an in-depth knowledge of the Mexican market, iLS Clinical Research CEO, Alejandro Arias, shares his insights on how to be the ideal…
Mayoly Spindler is an independent French family-run pharmaceutical company, which was established 80 years ago and has been able to grow and become consolidated as a mature, successful and dynamic group. Its activities cover several therapeutic areas such as gastroenterology, rheumatology, general medicine, general public health and dermocosmetics. Most of its products are produced in its three manufacturing sites in France, which are fully equipped with up-to-date means of production, control and shipment. The two main lines of development are in gastroenterology and dermocosmetics. The company is present internationally through affiliates in Russia, Algeria, Mexico, Brazil, Belgium and Spain, distributors in approximately 70 countries and plans to open more in the near future, among others in the US.
Positioning itself as a flexible local CRO with an in-depth knowledge of the Mexican market, iLS Clinical Research CEO, Alejandro Arias, shares his insights on how to be the ideal…
Eduardo Arce Parellada, General Manager at Sanofi Pasteur Mexico until March 2017, explains the positive impact that the vaccine against Dengue could generate for the national health system and showcases…
Gabriela Báez, Chief Commercial Officer of Up Pharma, elaborates on the company’s unique business model that supports small to medium sized pharmaceutical and preventative health companies in entering the Mexican…
Dominik Bacher, founder and CEO at Bacher Zoppi, explains the latest changes in the commercialization stage of the healthcare industry and showcases the value proposition of Bacher Zoppi to successfully…
José Antonio Garcia, CEO of Vensi, describes how the company’s unique service model is redefining how healthcare institutions approach the purchasing of medical equipment, while detailing the strategic significance of…
With an impressive achievement of growing the novel “flexible solutions” business unit by an astounding 50 percent in his first year of spearheading the region, Ricardo Uribe, Covance Mexico’s Director…
In charge of transforming the Monterrey-based family business of dermatological distribution into a Mexican corporate success story, Carlos de Kruyff, shares some of his most pertinent insights on the industry.…
Aimed to ignite a paradigm shift away from the current traditional distributor model, Salumedic’s Managing Director, Gabriel Tagle, shares the novel business concept with zeal and sharp business acumen. He…
The founder and Managing Director of Global Health Intelligence (GHI), Guillaume Corpart highlights the value of competitive intelligence for medical device companies looking to either enter emerging healthcare markets in…
Aristides Torres, CEO at Laboratorios Vanquish, explains how the company has evolved during the last five years to serve both the public and private markets and why they have focused…
Sergio Olivares, managing director at Olivares, explains the TPP’s impact on the Mexican pharmaceutical industry’s dynamism and Olivares’ business proposal as a one-stop shop solution to fulfill all its current…
“Equipment is not everything that GE can contribute with!” – The CEO and President of GE Healthcare’s Mexican Unit elaborates on how GE provides added value to its customers by…
See our Cookie Privacy Policy Here
